Browsing Tag
obesity
16 posts
Think GLP-1 drugs are a miracle? Wait until you hear about the hidden risks that nobody’s talking about! 😳
GLP-1 receptor agonists, a class of drugs initially developed to manage type 2 diabetes, have recently gained widespread…
Altimmune’s stock is on the rise—$20 price target, strong clinical data, could be the next big thing in the obesity drug market! 💊
Altimmune (ALT) stock is experiencing a significant upward movement, driven by multiple factors that have garnered investor attention.…
Viking Therapeutics is on fire! Q2 earnings beat expectations and obesity treatment advances to Phase 3! 🚀
Viking Therapeutics’ stock surged in after-hours trading on July 24, 2024, due to several positive developments. The company…
Altimmune’s obesity drug shows jaw-dropping 15.6% weight loss – could this be the future of weight loss? 💊
Positive Clinical Trial Results Propel Altimmune Altimmune (ALT) has recently caught the attention of investors, with its stock…
Drug approvals are skyrocketing! Why Thermo Fisher is the go-to partner for the biggest breakthroughs 💊
Thermo Fisher Scientific (TMO), a leading life sciences company, is experiencing growth due to the expanding GLP-1 drug…
Could this new class of drugs revolutionize healthcare? How GLP-1 drugs are changing the game 🔄
A groundbreaking new class of drugs has emerged from the laboratories of biopharma companies, promising to revolutionize the…
